5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS

The present invention discloses compounds according to Formula (I), wherein R, R2, R3a, R3b, and Cy are as defined herein. The present invention discloses compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same and methods for the prophylaxis and/or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Luke Jonathan ALVEY, David AMANTINI, Iuliana Ecaterina POP-BOTEZ, Pierre Marc Marie Joseph DEPREZ, Marie Laurence Clare VARIN, Romain Luc Marie GOSMINI, Helène Marie JARY, Franck Laurent BREBION, Christophe PEIXOTO, Frédéric André DE CEUNINCK
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Luke Jonathan ALVEY
David AMANTINI
Iuliana Ecaterina POP-BOTEZ
Pierre Marc Marie Joseph DEPREZ
Marie Laurence Clare VARIN
Romain Luc Marie GOSMINI
Helène Marie JARY
Franck Laurent BREBION
Christophe PEIXOTO
Frédéric André DE CEUNINCK
description The present invention discloses compounds according to Formula (I), wherein R, R2, R3a, R3b, and Cy are as defined herein. The present invention discloses compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same and methods for the prophylaxis and/or treatment of inflammatory conditions and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis. La presente invención describe compuestos de acuerdo con la Fórmula I: (ver formula) donde R', R2, R3a, R3b, y Cy son como se define en la presente descripción. La presente invención se refiere a compuestos para inhibir ADAMTS, métodos para su producción, composiciones farmacéuticas que comprenden las mismas y métodos de tratamiento utilizando las mismas, para la profilaxis y/o el tratamiento de las condiciones inflamatorias y/o de las enfermedades que involucran la degradación del cartílago y/o la interrupción de la homeostasis del cartílago, administrando un compuesto de la invención.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2017008048A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2017008048A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2017008048A3</originalsourceid><addsrcrecordid>eNqNyj0KwkAQQOE0FqLeYbFScCB_ou3qTshAshN2h5AoIiJrJSpo7dm18ADCg695w-i9hP2soQad3pGFBPpqDhlwx9A4bvrqAFST0TuuyJBFSBc5GGKLyqCjVgu16JX-ZnQtXpEtaUPCzquCnZISlTjUUqMVxYViL8jaSelIyI-jweV0fYbJz1E0LVC2JYTH_Riej9M53MLrWHdpnKzieB3na539NX0AS9M8HA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS</title><source>esp@cenet</source><creator>Luke Jonathan ALVEY ; David AMANTINI ; Iuliana Ecaterina POP-BOTEZ ; Pierre Marc Marie Joseph DEPREZ ; Marie Laurence Clare VARIN ; Romain Luc Marie GOSMINI ; Helène Marie JARY ; Franck Laurent BREBION ; Christophe PEIXOTO ; Frédéric André DE CEUNINCK</creator><creatorcontrib>Luke Jonathan ALVEY ; David AMANTINI ; Iuliana Ecaterina POP-BOTEZ ; Pierre Marc Marie Joseph DEPREZ ; Marie Laurence Clare VARIN ; Romain Luc Marie GOSMINI ; Helène Marie JARY ; Franck Laurent BREBION ; Christophe PEIXOTO ; Frédéric André DE CEUNINCK</creatorcontrib><description>The present invention discloses compounds according to Formula (I), wherein R, R2, R3a, R3b, and Cy are as defined herein. The present invention discloses compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same and methods for the prophylaxis and/or treatment of inflammatory conditions and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis. La presente invención describe compuestos de acuerdo con la Fórmula I: (ver formula) donde R', R2, R3a, R3b, y Cy son como se define en la presente descripción. La presente invención se refiere a compuestos para inhibir ADAMTS, métodos para su producción, composiciones farmacéuticas que comprenden las mismas y métodos de tratamiento utilizando las mismas, para la profilaxis y/o el tratamiento de las condiciones inflamatorias y/o de las enfermedades que involucran la degradación del cartílago y/o la interrupción de la homeostasis del cartílago, administrando un compuesto de la invención.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171019&amp;DB=EPODOC&amp;CC=MX&amp;NR=2017008048A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171019&amp;DB=EPODOC&amp;CC=MX&amp;NR=2017008048A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Luke Jonathan ALVEY</creatorcontrib><creatorcontrib>David AMANTINI</creatorcontrib><creatorcontrib>Iuliana Ecaterina POP-BOTEZ</creatorcontrib><creatorcontrib>Pierre Marc Marie Joseph DEPREZ</creatorcontrib><creatorcontrib>Marie Laurence Clare VARIN</creatorcontrib><creatorcontrib>Romain Luc Marie GOSMINI</creatorcontrib><creatorcontrib>Helène Marie JARY</creatorcontrib><creatorcontrib>Franck Laurent BREBION</creatorcontrib><creatorcontrib>Christophe PEIXOTO</creatorcontrib><creatorcontrib>Frédéric André DE CEUNINCK</creatorcontrib><title>5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS</title><description>The present invention discloses compounds according to Formula (I), wherein R, R2, R3a, R3b, and Cy are as defined herein. The present invention discloses compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same and methods for the prophylaxis and/or treatment of inflammatory conditions and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis. La presente invención describe compuestos de acuerdo con la Fórmula I: (ver formula) donde R', R2, R3a, R3b, y Cy son como se define en la presente descripción. La presente invención se refiere a compuestos para inhibir ADAMTS, métodos para su producción, composiciones farmacéuticas que comprenden las mismas y métodos de tratamiento utilizando las mismas, para la profilaxis y/o el tratamiento de las condiciones inflamatorias y/o de las enfermedades que involucran la degradación del cartílago y/o la interrupción de la homeostasis del cartílago, administrando un compuesto de la invención.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyj0KwkAQQOE0FqLeYbFScCB_ou3qTshAshN2h5AoIiJrJSpo7dm18ADCg695w-i9hP2soQad3pGFBPpqDhlwx9A4bvrqAFST0TuuyJBFSBc5GGKLyqCjVgu16JX-ZnQtXpEtaUPCzquCnZISlTjUUqMVxYViL8jaSelIyI-jweV0fYbJz1E0LVC2JYTH_Riej9M53MLrWHdpnKzieB3na539NX0AS9M8HA</recordid><startdate>20171019</startdate><enddate>20171019</enddate><creator>Luke Jonathan ALVEY</creator><creator>David AMANTINI</creator><creator>Iuliana Ecaterina POP-BOTEZ</creator><creator>Pierre Marc Marie Joseph DEPREZ</creator><creator>Marie Laurence Clare VARIN</creator><creator>Romain Luc Marie GOSMINI</creator><creator>Helène Marie JARY</creator><creator>Franck Laurent BREBION</creator><creator>Christophe PEIXOTO</creator><creator>Frédéric André DE CEUNINCK</creator><scope>EVB</scope></search><sort><creationdate>20171019</creationdate><title>5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS</title><author>Luke Jonathan ALVEY ; David AMANTINI ; Iuliana Ecaterina POP-BOTEZ ; Pierre Marc Marie Joseph DEPREZ ; Marie Laurence Clare VARIN ; Romain Luc Marie GOSMINI ; Helène Marie JARY ; Franck Laurent BREBION ; Christophe PEIXOTO ; Frédéric André DE CEUNINCK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2017008048A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Luke Jonathan ALVEY</creatorcontrib><creatorcontrib>David AMANTINI</creatorcontrib><creatorcontrib>Iuliana Ecaterina POP-BOTEZ</creatorcontrib><creatorcontrib>Pierre Marc Marie Joseph DEPREZ</creatorcontrib><creatorcontrib>Marie Laurence Clare VARIN</creatorcontrib><creatorcontrib>Romain Luc Marie GOSMINI</creatorcontrib><creatorcontrib>Helène Marie JARY</creatorcontrib><creatorcontrib>Franck Laurent BREBION</creatorcontrib><creatorcontrib>Christophe PEIXOTO</creatorcontrib><creatorcontrib>Frédéric André DE CEUNINCK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Luke Jonathan ALVEY</au><au>David AMANTINI</au><au>Iuliana Ecaterina POP-BOTEZ</au><au>Pierre Marc Marie Joseph DEPREZ</au><au>Marie Laurence Clare VARIN</au><au>Romain Luc Marie GOSMINI</au><au>Helène Marie JARY</au><au>Franck Laurent BREBION</au><au>Christophe PEIXOTO</au><au>Frédéric André DE CEUNINCK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS</title><date>2017-10-19</date><risdate>2017</risdate><abstract>The present invention discloses compounds according to Formula (I), wherein R, R2, R3a, R3b, and Cy are as defined herein. The present invention discloses compounds inhibiting ADAMTS, methods for their production, pharmaceutical compositions comprising the same and methods for the prophylaxis and/or treatment of inflammatory conditions and/or diseases involving degradation of cartilage and/or disruption of cartilage homeostasis. La presente invención describe compuestos de acuerdo con la Fórmula I: (ver formula) donde R', R2, R3a, R3b, y Cy son como se define en la presente descripción. La presente invención se refiere a compuestos para inhibir ADAMTS, métodos para su producción, composiciones farmacéuticas que comprenden las mismas y métodos de tratamiento utilizando las mismas, para la profilaxis y/o el tratamiento de las condiciones inflamatorias y/o de las enfermedades que involucran la degradación del cartílago y/o la interrupción de la homeostasis del cartílago, administrando un compuesto de la invención.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2017008048A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T18%3A07%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Luke%20Jonathan%20ALVEY&rft.date=2017-10-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2017008048A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true